An announcement from BetterLife Pharma ( ($TSE:BETR) ) is now available. BetterLife Pharma has appointed Doug Drysdale as Corporate Advisor to ...
LSD reduced symptoms of anxiety in a midstage study published Thursday, paving the way for additional testing and possible medical approval of a psychedelic drug that has been banned in the U.S. for ...
A single dose of LSD can cut anxiety in half within weeks, according to the results of a new study conducted by a biopharmaceutical company. MindMed, a clinical-stage company that develops novel ...
Among psychedelic enthusiasts, April 19 or Bicycle Day honors a mind-altering ride taken by the Swiss chemist who created LSD. Bicycle Day marks a hallucinogenic ride that's considered the birth of ...
A clinical trial’s encouraging results won US Food and Drug Administration breakthrough therapy status for an LSD formulation to treat generalized anxiety disorder, Mind Medicine Inc. announced ...
A new study finds that a single dose of LSD can ease a person's anxiety for months. This could give legitimacy to research on a range of psychedelics. A rigorous new study finds that a single dose of ...
BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE: BETR / OTCQB : BETRF / FRA: NPAU), an emerging biotech company, has announced that it has appointed Doug Drysdale, former ...